DomovMEHCQ • OTCMKTS
add
23andMe Holding Co.
Predch. zatv. cena
1,17 $
Denný rozsah
1,07 $ - 1,18 $
Rozsah rokov
0,48 $ - 12,76 $
Trhová kapitalizácia
30,85 mil. USD
Priemerný objem
8,09 mil.
Cena/zisk
-
Dividendový výnos
-
Hlavná burza
OTCMKTS
V správach
Finančné údaje
Výkaz ziskov a strát
Výnosy
Čisté príjmy
(USD) | 12/2024info | Zmena medziročne |
---|---|---|
Výnosy | 60,26 mil. | 34,67 % |
Prevádzkové náklady | 65,06 mil. | -22,18 % |
Čisté príjmy | -53,04 mil. | 80,92 % |
Čistá zisková marža | -88,01 | 85,83 % |
Earnings per share | — | — |
Zisk pred zdanením, úrokmi, odpismi | -21,80 mil. | 62,70 % |
Skutočná daňová sadzba | — | — |
Súvaha
Celkové aktíva
Celkové záväzky
(USD) | 12/2024info | Zmena medziročne |
---|---|---|
Hotovosť a krátk. invest. | 79,35 mil. | -67,27 % |
Celkové aktíva | 277,42 mil. | -54,39 % |
Celkové záväzky | 214,70 mil. | -7,06 % |
Celkový kapitál | 62,72 mil. | — |
Shares outstanding | 26,83 mil. | — |
Pomer ceny a účt. hodnoty | 0,50 | — |
Rentabilita aktív | -21,15 % | — |
Rentabilita kapitálu | -42,49 % | — |
Peňažný tok
Čistá zmena množstva peňažných prostriedkov
(USD) | 12/2024info | Zmena medziročne |
---|---|---|
Čisté príjmy | -53,04 mil. | 80,92 % |
Prevádzkový peňažný tok | -44,65 mil. | -270,23 % |
Peniaze z investícií | 887,00 tis. | 144,09 % |
Peniaze z financovania | -19,00 tis. | -118,10 % |
Čistá zmena množstva peňažných prostriedkov | -43,79 mil. | -213,47 % |
Voľný peňažný tok | -20,18 mil. | -469,10 % |
Informácie
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Dátum založenia
apr 2006
Web
Zamestnanci
571